Nanopharmaceuticals

Volume 1: Expectations and Realities of Multifunctional Drug Delivery Systems
Erscheinungsjahr 2020
ISBN: 978-0-12-817778-5
Verlag: Elsevier Science

Buch, Englisch, 244 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 450 g

Nanopharmaceuticals reviews advances in the drug delivery field via nanovehicles or nanocarriers that offer benefits like targeted therapy and serves as a single dose magic bullet for multiple drug delivery with improved drug efficiency at a lower dose, transportation of the drug across physiological barriers as well as reduced drug-related toxicity. The chapters are written by a diverse group of international researchers from industry and academia.

The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.

Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.

Other volumes in the Expectations and Realities of Multifunctional Drug Delivery Systems book series:

Delivery of Drugs, Volume 2, 9780128177761

Drug Delivery Trends, Volume 3, 9780128178706

Drug Delivery Aspects, Volume 4, 9780128212226

Zielgruppe

Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers

Autoren/Hrsg.

Shegokar, Ranjita

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie

Inhaltsverzeichnis

1. Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties
J.R. CAMPOS, P. SEVERINO, A. SANTINI, A.M. SILVA, RANJITA SHEGOKAR, S.B. SOUTO, AND E.B. SOUTO
2. Role of nanocarriers and their surface modification in targeting delivery of bioactive compounds
HENI RACHMAWATI, ATSARINA LARASATI, ANNIS CATUR ADI, AND RANJITA SHEGOKAR
3. Polymeric nanomicelles as versatile tool for multidrug delivery in chemotherapy
KOBRA ROSTAMIZADEH AND VLADIMIR P. TORCHILIN
4. Nanoparticulate systems for wound healing
MAHA NASR, RIHAM I. EL-GOGARY, HEND ABD-ALLAH, AND MONA ABDEL-MOTTALEB
5. Solid dispersions: technologies used and future outlook
N.B. JADAV AND A. PARADKAR
6. Nanotoxicity: the impact of increasing drug bioavailability
JUAN BUENO
7. Nanoparticle-based vaccines: opportunities and limitations
DIANA DIAZ-ARÉVALO AND MINGTAO ZENG
8. Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs
ANÐELKA B. KOVACEVIC
9. Nose-to-brain drug delivery: an alternative approach for effective brain drug targeting
AMIT ALEXANDER, MUKTA AGRAWAL, MAHAVIR BHUPAL CHOUGULE, SHAILENDRA SARAF, AND SWARNLATA SARAF
10. Trends in the intellectual property (IP) landscape of drug delivery systems: 30 years of growth and evolution
AMANDA STARLING-WINDHOF, ASUR SRINIVASAN, TINA TOMEO, ANNE MARIE CLARK, AND PETER MATTEI

Über Autor(innen)

Shegokar, Ranjita
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)